a public good project by the
Synthesis
Company
of California

© 2026

Rolf-Peter Ryseck | doi.page

0 works0 citations0 h-index

Rolf-Peter Ryseck

Princeton University(US)Institute for Integrative and Experimental Genomics(DE)Ludwig Cancer Research(US)

Publications by Year

Research Areas

NF-κB Signaling Pathways, Cancer, Hypoxia, and Metabolism, Metabolomics and Mass Spectrometry Studies, Cancer, Lipids, and Metabolism, Immune Response and Inflammation

Most-Cited Works

→ Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NF-κB/Rel family(1995)803 cited
→ Transcriptional activation of c-jun during the G0/G1 transition in mouse fibroblasts(1988)574 cited
→ The product of a novel growth factor activated gene, fos B, interacts with JUN proteins enhancing their DNA binding activity.(1989)560 cited
→ Characterization of junD: a new member of the jun proto-oncogene family.(1989)482 cited
→ RelB, a new Rel family transcription activator that can interact with p50-NF-kappa B.(1992)354 cited
→ Cancer Cell Dependence on Unsaturated Fatty Acids Implicates Stearoyl-CoA Desaturase as a Target for Cancer Therapy(2011)275 cited

→ A novel mitogen-inducible gene product related to p50/p105-NF-kappa B participates in transactivation through a kappa B site.(1992)271 cited

→ Impaired Macrophage Function and Enhanced T Cell-Dependent Immune Response in Mice Lacking CCR5, the Mouse Homologue of the Major HIV-1 Coreceptor(1998)248 cited

→ Structure, mapping and expression of a growth factor inducible gene encoding a putative nuclear hormonal binding receptor.(1989)187 cited

→ Gastric Hyperplasia and Increased Proliferative Responses of Lymphocytes in Mice Lacking the COOH-terminal Ankyrin Domain of NF-κB2(1997)174 cited